Search results
Bayer: The pharmaceutical company behind Leverkusen's success - and its difficult past
New York Times· 5 days agoUnder head coach Xabi Alonso, Bayer Leverkusen have won the Bundesliga and are on the cusp of...
Asthma, COPD often not diagnosed, study indicates
UPI· 6 days agoFinding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for...
Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
Insider Monkey via Yahoo Finance· 3 days agoIn this article, we will be taking a look at is Eli Lilly and Company the largest publicly traded...
WHO updates list of most dangerous drug-resistant pathogens
Becker’s Hospital Review· 2 days agoFor the first time in seven years, the World Health Organization has updated its list of the most dangerous, antimicrobial resistant pathogens. The revised list includes 24 pathogens from 15 ...
Evotec (EVO) to Release Earnings on Wednesday
ETF DAILY NEWS· 5 days agoEvotec (NASDAQ:EVO – Get Free Report) is set to release its earnings data before the market opens on Wednesday, May 22nd. Analysts expect Evotec to post earnings of ($0.07) per share for the ...
Molecular Identification of Fonsecaea monophora, Novel Agent of Fungal Brain Abscess
Centers for Disease Control and Prevention· 2 days agoA 3-year-old boy was admitted to the All India Institute of Medical Sciences, New Delhi, India, with headache for 3 weeks and 2 episodes of seizures. Fundoscopic examination revealed bilateral ...
TB has reclaimed its place as the world’s biggest infectious killer – but are its days numbered?
Daily Telegraph· 6 days agoAs patients’ immune systems were weakened by the new disease, there was a surge in TB. HIV caused 55...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...
Benzinga· 5 days agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech ALVO, today announced the availability of SIMLANDI (adalimumab-ryvk) injection ...
WHO report shows sexually transmitted infections are climbing
Center for Infectious Disease Research and Policy· 3 days agoA new report from the World Health Organization (WHO) shows that 2 years into a global effort to...
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 5 days agoIn Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active Crohn's disease, with or without previous biologic failure, achieved statistically ...